ENDLOS-TURBO PUT - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 20:34:41 14/06/2024 BST | ||
| 9.68 EUR | +2.00% |
|
| Current month | -5.38% | ||
| 1 month | -3.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 9.68 | +2.00% |
| 13/06/24 | 9.49 | -3.46% |
| 12/06/24 | 9.83 | -2.77% |
| 11/06/24 | 10.11 | -0.39% |
| 10/06/24 | 10.15 | +0.10% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 08:34 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DW7X6S |
| ISIN | DE000DW7X6S7 |
| Date issued | 24/11/2022 |
| Strike | 332.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.95 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.61 € |
|---|---|
| Lowest since issue | 0.73 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat
